title: Renal function as a predictor of linezolid-induced thrombocytopenia.
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Matsumoto
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Takeda
authors.forename: Ayumi
authors.initials: A
authors.lastname: Takeshita
authors.forename: Naoko
authors.initials: N
authors.lastname: Fukunaga
authors.forename: Akari
authors.initials: A
authors.lastname: Shigemi
authors.forename: Keiko
authors.initials: K
authors.lastname: Yaji
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Shimodozono
authors.forename: Katsushi
authors.initials: K
authors.lastname: Yamada
authors.forename: Kazuro
authors.initials: K
authors.lastname: Ikawa
authors.forename: Norifumi
authors.initials: N
authors.lastname: Morikawa
mesh_terms: D000081:Acetamides / Q000009:adverse effects*; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects*; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood*; D005260:Female; D006801:Humans; D007677:Kidney Function Tests / Q000379:methods; D000069349:Linezolid; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D023303:Oxazolidinones / Q000009:adverse effects*; D011237:Predictive Value of Tests; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013921:Thrombocytopenia / Q000139:chemically induced*; D016896:Treatment Outcome
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D003404:Creatinine; D000069349:Linezolid